Status:
UNKNOWN
RCT Long COVID-19 Rehabilitation
Lead Sponsor:
University Hospital of North Norway
Collaborating Sponsors:
University of Bergen
Oslo University Hospital
Conditions:
Rehabilitation
Post-Acute COVID-19 Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The Coronavirus 2019 (COVID-19) pandemic has resulted in at least four million infections in Norway. The vast majority of cases are diagnosed and followed up in the community, but some with extensive ...
Eligibility Criteria
Inclusion
- Symptoms attributable to long COVID according to WHO definition \[14\] that affect their daily activities
- Positive Covid test; a home-test, PCR test or serology.
- Neurocognitive symptoms
- Age between 18 and 65 years
- Participant is able and willing to provide informed consent
Exclusion
- Patients that do not want to comply to planned physical study visits
- Patients who are unable to complete surveys in Norwegian
- Patients with known chronic neurocognitive disease before Covid-19 or other diseases that can explain current symptoms
Key Trial Info
Start Date :
November 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06085911
Start Date
November 3 2023
End Date
November 1 2025
Last Update
June 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of North Norway
Tromsø, Troms, Norway, 9038